Antibiotic management of Staphylococcus aureus infections in US children's hospitals, 1999-2008

Joshua C Herigon1, Adam L Hersh, Jeffrey S Gerber

  • 1Children's Mercy Hospital and Clinics, Section of Infectious Diseases, 2401 Gillham Rd, Kansas City, MO 64108, USA.

Pediatrics
|May 19, 2010
PubMed

Insights

Antibiotic prescribing for pediatric Staphylococcus aureus infections shifted significantly, with clindamycin becoming the most common treatment due to rising MRSA rates. Continuous monitoring of bacterial susceptibility is crucial.

Area of Science:

  • Pediatric Infectious Diseases
  • Antimicrobial Stewardship
  • Clinical Pharmacy

Background:

  • Antibiotic management for Staphylococcus aureus (S aureus) infections in children requires understanding evolving resistance patterns.
  • The emergence of methicillin-resistant S aureus (MRSA) has altered treatment strategies.
  • Trends in pediatric S aureus treatment are not well-characterized.

Purpose of the Study:

  • To describe trends in antibiotic management for S aureus infections in hospitalized children.
  • To analyze changes in antibiotic use from 1999 to 2008.

Main Methods:

  • Retrospective study using the Pediatric Health Information Systems database.
  • Included inpatients with S aureus infection codes (1999-2008) at 25 US children's hospitals.
  • Examined trends in vancomycin, clindamycin, linezolid, trimethoprim-sulfamethoxazole, cefazolin, and oxacillin/nafcillin use.

Main Results:

  • S aureus infections increased, with MRSA rising tenfold (2 to 21 per 1000 admissions).
  • Antibiotics treating MRSA increased from 52% to 79%; those treating only methicillin-susceptible S aureus declined.
  • Clindamycin use surged from 21% to 63% between 1999 and 2008.

Conclusions:

  • Antibiotic prescribing patterns for pediatric S aureus infections have significantly changed.
  • The rise of community-associated MRSA has driven shifts towards agents like clindamycin.
  • Ongoing surveillance of S aureus susceptibility is essential for effective treatment.
Abstract

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...